In this study, by Prelle et al, the frequency of RAS mutations is higher in pediatric than adult patients (26% vs 8%).30 Nevertheless, the authors neglect that these additional mutations might be the second hits for early onset of KMT2A-AFF1 ALL. Here, AFF1 is linked to acute lymphoblastic leukemia.